Trauma is associated with a better prognosis in intensive care patients with Acinetobacter infections

Infection

Volumn 42, Issue 1, 2014, Pages 89-95

  Tonacio, A C ^a   Oliveira, M S ^a   Malbouisson, L M S ^a   Levin, A S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acinetobacter; ICU; Mortality; Trauma

Indexed keywords

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; APACHE; ARTICLE; ASYMPTOMATIC BACTERIURIA; BATTLE INJURY; CITROBACTER KOSERI; CLINICAL ARTICLE; CRITICALLY ILL PATIENT; FEMALE; GLASGOW COMA SCALE; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; MALE; MEDICAL RECORD REVIEW; MORTALITY; PROGNOSIS; PROTEUS MIRABILIS; PROVIDENCIA STUARTII; RETROSPECTIVE STUDY; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA;

ACINETOBACTER INFECTIONS; ADULT; AGED; HUMANS; INTENSIVE CARE; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 84898540458     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-013-0523-y     Document Type: Article

References (20)

1. Falagas ME, Bliziotis IA, Siempos II. Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies. Crit Care. 2006;10:R48.
2. Garcia-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, Jimenez-Jimenez FJ, Monterrubio-Villar J, Gili-Miner M. Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients. Crit Care Med. 1999;27:1794-9. (Pubitemid 29455106)
3. Lortholary O, Fagon JY, Hoi AB, Slama MA, Pierre J, Giral P, Rosenzweig R, Gutmann L, Safar M, Acar J. Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis. Clin Infect Dis. 1995;20:790-6.
4. Blot S, Vandewoude K, Colardyn F. Nosocomial bacteremia involving Acinetobacter spp. in critically ill patients: a matched cohort study. Intensive Care Med. 2003;29:471-5. (Pubitemid 36379452)
5. Weingarten CM, Rybak MJ, Jahns BE, Stevenson JG, Brown WJ, Levine DP. Evaluation of Acinetobacter baumannii infection and colonization, and antimicrobial treatment patterns in an urban teaching hospital. Pharmacotherapy. 1999;19:1080-5. (Pubitemid 29413647)
6. Trottier V, Namias N, Pust DG, Nuwayhid Z, Manning R, Marttos AC Jr, Dunham MB, Schulman CI, McKenney MG. Outcomes of Acinetobacter baumannii infection in critically ill surgical patients. Surg Infect (Larchmt). 2007;8:437-43. (Pubitemid 47493521)
7. Jang TN, Lee SH, Huang CH, Lee CL, Chen WY. Risk factors and impact of nosocomial Acinetobacter spp. bloodstream infections in the adult intensive care unit: a case-control study. J Hosp Infect. 2009;73:143-50.
8. Sebeny PJ, Riddle MS, Petersen K. Acinetobacter spp. skin and soft-tissue infection associated with war trauma. Clin Infect Dis. 2008;47:444-9.
9. Caricato A, Montini L, Bello G, Michetti V, Maviglia R, Bocci MG, Mercurio G, Maggiore SM, Antonelli M. Risk factors and outcome of Acinetobacter baumannii infection in severe trauma patients. Intensive Care Med. 2009;35:1964-9.
10. Kang G, Hartzell JD, Howard R, Wood-Morris RN, Johnson MD, Fraser S, Weintrob A, Wortmann G. Mortality associated with Acinetobacter spp. complex bacteremia among patients with war-related trauma. Infect Control Hosp Epidemiol. 2010;31:92-4.
11. Eberle BM, Schnüriger B, Putty B, Barmparas G, Kobayashi L, Inaba K, Belzberg H, Demetriades D. The impact of Acinetobacter baumannii infections on outcome in trauma patients: a matched cohort study. Crit Care Med. 2010;38:2133-8.
12. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309-32. (Pubitemid 351763841)
13. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-29. (Pubitemid 15250137)
14. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2:81-4.
15. Erbay A, Idil A, Gozel MG, Mumcuoglu I, Balaban N. Impact of early appropriate antimicrobial therapy on survival in Acinetobacter baumannii bloodstream infections. Int J Antimicrob Agents. 2009;34:575-9.
16. Tuon FF, Rymsza AM, Penteado-Filho SR, Pilonetto M, Arend LN, Levin AS. Should polymyxin be used empirically to treat infections in patients under high risk for carbapenem-resistant Acinetobacter? J Infect. 2011;62:246-9.
17. Breslow JM, Monroy MA, Daly JM, Meissler JJ, Gaughan J, Adler MW, Eisenstein TK. Morphine, but not trauma, sensitizes to systemic Acinetobacter baumannii infection. J Neuroimmune Pharmacol. 2011;6:551-65.
18. Howard A, O'Donoghue M, Feeney A, Sleator RD. Acinetobacter baumannii-an emerging opportunistic pathogen. Virulence. 2012;3:1-8.
19. Iwashkiw JA, Seper A, Weber BS, Scott NE, Vinogradov CS, Reiz B. CordwellSJ, Whittal R, Schild S, Feldman MF. Identification of a general O-linked Protein Glycosylation System in Acinetobacter baumannii and its role in virulence and biolfilm formation. PLoS Pathog. 2012;8:e1002758.
20. Lee NY, Chang TC, Wu CJ, Chang CM, Lee HC, Chen PL, Lee CC, Ko NY, Ko WC. Clinical manifestations, antimicrobial therapy, and prognostic factors of monocrobial Acinetobacter baumannii complex bacteremia. J Infect. 2010;61:219-27.